Breaking News

PharmaNet/i3 Renamed inVentiv Health Clinical

January 30, 2013

Reflects alignment of clinical segment and commercial and consulting services

PharmaNet/i3 has been renamed to inVentiv Health, Inc. to reflect the closer alignment between the clinical segment and the company’s commercial and consulting services.
 
“As a top global CRO, renaming ourselves inVentiv Health Clinical demonstrates a company-wide commitment to our clinical clients, who will benefit from seamless, global access to a more robust range of services,” said Paul Meister, chief executive officer at inVentiv Health. “Clients can now access broad inVentiv talent with expertise across the product life cycle to deliver tailored solutions from product development through commercialization.”
 
Raymond Hill, who was appointed to lead inVentiv Health Clinical in December, said, “By connecting clinical research and staffing capabilities to consulting and commercial services, inVentiv can offer fully integrated solutions to pharmaceutical, biotechnology, generic drug and medical device companies in a way that cannot be matched by any other CRO in the industry. One example is our ability to assist clients in Late Stage trials by tapping both digital and adherence experts from other inVentiv companies. Through this approach we can help our clients simplify complex health economics and outcomes research trials.”
  • Packaging Equipment Technology Preview

    Packaging Equipment Technology Preview

    February 15, 2017
    Today’s complex drug products present challenges; the latest equipment capabilities help overcome them

  • The Good, the Bad, and the Donald

    The Good, the Bad, and the Donald

    January 31, 2017
    Orphan drugs, CMO continuous manufacturing and developing world sales offer biggest revenue opportunities

  • Predictive Analytics and the Future of RBM

    Rajneesh Patil, Senior Director, RBM and Analytics, QuintilesIMS||January 23, 2017
    How advances in Risk-Based Monitoring will enable a more proactive approach to identify and mitigate potential risks